KALA BIO Inc
KALA7.375USD
-0.125-1.67%
交易中 （美東）報價延遲15分鐘
47.59M總市值
虧損本益比TTM
關於 KALA BIO Inc 公司
KALA BIO, Inc. 是一家臨牀階段的生物製藥公司。該公司從事罕見和嚴重眼部疾病療法的研究、開發和商業化。該公司基於生物製劑的試驗療法利用其專有的間充質幹細胞分泌組 (MSC-S) 平臺。該公司的候選產品 KPI-012 是一種人類 MSC-S，它含有多種人類衍生的生物因子，例如生長因子、蛋白酶抑制劑、基質蛋白和神經營養因子，可以潛在地糾正角膜癒合受損，這是多種嚴重眼部疾病的潛在病因。其 KPI-012 用於治療持續性角膜上皮缺損 (PCED)，這是一種罕見的角膜癒合受損疾病。該公司還致力於開發 KPI-012 用於治療角膜緣幹細胞缺乏症和其他罕見角膜疾病。
公司簡介
公司代碼KALA
公司名稱KALA BIO Inc
上市日期Jul 20, 2017
CEOMr. Todd M. Bazemore
員工數量38
證券類型Ordinary Share
年結日Jul 20
公司地址1167 Massachusetts Avenue
城市ARLINGTON
上市交易所NASDAQ Capital Market Consolidated
國家United States of America
郵編02476
電話17819965252
網址https://www.kalarx.com/
公司代碼KALA
上市日期Jul 20, 2017
CEOMr. Todd M. Bazemore
公司高階主管
名稱
名稱/職務
職務
持股
持股變動
Mr. Darius Kharabi
Mr. Darius Kharabi
Chief Business Officer
Chief Business Officer
62.57K
-7.73%
Mr. Todd M. Bazemore
Mr. Todd M. Bazemore
President, Interim Chief Executive Officer, Chief Operating Officer
President, Interim Chief Executive Officer, Chief Operating Officer
22.77K
-15.13%
Mr. Andrew Ian Koven
Mr. Andrew Ian Koven
Lead Independent Director
Lead Independent Director
3.05K
--
Mr. Howard B. (Howie) Rosen
Mr. Howard B. (Howie) Rosen
Independent Director
Independent Director
2.71K
+935.11%
Dr. Marjan Farid, M.D.
Dr. Marjan Farid, M.D.
Independent Director
Independent Director
2.45K
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Independent Director
Independent Director
2.45K
--
Ms. Mary Reumuth
Ms. Mary Reumuth
Chief Financial Officer, Treasurer, Secretary
Chief Financial Officer, Treasurer, Secretary
--
--
Mr. Mark T. Iwicki
Mr. Mark T. Iwicki
Chairman of the Board
Chairman of the Board
--
--
Dr. Kim Brazzell, Ph.D.
Dr. Kim Brazzell, Ph.D.
Head of Research and Development, Chief Medical Officer
Head of Research and Development, Chief Medical Officer
--
--
Mr. C. Daniel Myers
Mr. C. Daniel Myers
Independent Director
Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Darius Kharabi
Mr. Darius Kharabi
Chief Business Officer
Chief Business Officer
62.57K
-7.73%
Mr. Todd M. Bazemore
Mr. Todd M. Bazemore
President, Interim Chief Executive Officer, Chief Operating Officer
President, Interim Chief Executive Officer, Chief Operating Officer
22.77K
-15.13%
Mr. Andrew Ian Koven
Mr. Andrew Ian Koven
Lead Independent Director
Lead Independent Director
3.05K
--
Mr. Howard B. (Howie) Rosen
Mr. Howard B. (Howie) Rosen
Independent Director
Independent Director
2.71K
+935.11%
Dr. Marjan Farid, M.D.
Dr. Marjan Farid, M.D.
Independent Director
Independent Director
2.45K
--
Mr. Gregory D. (Greg) Perry
Mr. Gregory D. (Greg) Perry
Independent Director
Independent Director
2.45K
--
收入明細
暫無數據
暫無數據
業務
地區
暫無數據
股東統計
更新時間: 5月17日 週六
更新時間: 5月17日 週六
持股股東
股東類型
持股股東
持股股東
佔比
Baker Bros. Advisors LP
18.63%
Cormorant Asset Management, LP
9.35%
SR One Capital Management, LP
9.28%
Adar1 Capital Management LLC
4.63%
Perceptive Advisors LLC
4.30%
Other
53.81%
持股股東
持股股東
佔比
Baker Bros. Advisors LP
18.63%
Cormorant Asset Management, LP
9.35%
SR One Capital Management, LP
9.28%
Adar1 Capital Management LLC
4.63%
Perceptive Advisors LLC
4.30%
Other
53.81%
股東類型
持股股東
佔比
Hedge Fund
43.08%
Venture Capital
9.28%
Private Equity
7.65%
Individual Investor
3.44%
Investment Advisor
2.78%
Investment Advisor/Hedge Fund
2.43%
Research Firm
0.02%
Other
31.32%
機構持股
更新時間: 7月1日 週二
更新時間: 7月1日 週二
報告期間
機構數
持股數
持股佔比
持股變動
2025Q2
83
4.43M
68.68%
+337.01K
2025Q1
87
4.55M
70.65%
+406.89K
2024Q4
88
3.89M
64.57%
+719.01K
2024Q3
107
2.55M
53.72%
-568.60K
2024Q2
124
2.52M
53.27%
+878.66K
2024Q1
153
1.32M
46.57%
-352.41K
2023Q4
174
1.22M
46.23%
-240.85K
2023Q3
220
1.43M
56.63%
+307.93K
2023Q2
244
1.30M
52.70%
+147.16K
2023Q1
256
646.20K
33.12%
-414.92K
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Baker Bros. Advisors LP
1.20M
18.63%
--
--
Mar 31, 2025
Cormorant Asset Management, LP
603.03K
9.35%
--
--
Mar 31, 2025
SR One Capital Management, LP
598.94K
9.28%
--
--
Mar 31, 2025
Adar1 Capital Management LLC
298.95K
4.63%
+78.58K
+35.66%
Mar 31, 2025
Perceptive Advisors LLC
277.61K
4.3%
+277.61K
--
Mar 31, 2025
Woodline Partners LP
258.77K
4.01%
+258.77K
--
Mar 31, 2025
SilverArc Capital Management, LLC
246.08K
3.81%
+15.01K
+6.50%
Mar 31, 2025
AIGH Capital Management, LLC.
147.73K
2.29%
+57.26K
+63.29%
Mar 31, 2025
UBS O'Connor LLC
170.92K
2.65%
-8.02K
-4.48%
Mar 31, 2025
The Vanguard Group, Inc.
152.78K
2.37%
+99.20K
+185.19%
Mar 31, 2025
查看更多
持股ETF
更新時間: 8月2日 週六
更新時間: 8月2日 週六
機構名稱
佔比
iShares Micro-Cap ETF
0%
iShares Core S&P Total U.S. Stock Market ETF
0%
iShares Micro-Cap ETF
佔比0%
iShares Core S&P Total U.S. Stock Market ETF
佔比0%
分紅派息
近5年累計派現
0.00
美元
公告日期
分紅計劃
股權登記日
現金發放日
除權除息日
暫無數據
拆合股
公告日期
類型
比率
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
公告日期
類型
比率
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
Oct 20, 2022
Merger
50<1
